Renal artery stenosis evaluation: Diagnostic performance of gadobenate dimeglumine - Enhanced MR angiography - Comparison with DSA

Radiology

Volumn 247, Issue 1, 2008, Pages 273-285

  Soulez, Gilles ^a,b   Pasowicz, Mieczyslaw ^c   Benea, Giorgio ^d   Grazioli, Luigi ^e   Niedmann, Juan Pablo ^f   Konopka, Marek ^g   Douek, Philippe C ^h   Morana, Giovanni ⁱ   Schaefer, Fritz K W ^j   Vanzulli, Angelo ^k   Bluemke, David A ^l   Maki, Jeffrey H ^m   Prince, Martin R ⁿ   Schneider, Günther ^o   Ballarati, Claudio ^p   Coulden, Richard ^q   Wasser, Martin N ^r   McCauley, Thomas R ^s   Kirchin, Miles A ^t   Pirovano, Gianpaolo ^u  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c Krakowski Szpital Specjalistyczny Im Jana Pawła II   (Poland)

^d Delta Hospital   (Italy)

^e UNIVERSITY OF BRESCIA   (Italy)

^f HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

^g Helimed Diagnostic Imaging Sp z oo   (Poland)

^h LOUIS PRADEL HOSPITAL   (France)

ⁱ University Hospital of Treviso   (Italy)

^j UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^k OSPEDALE NIGUARDA CA GRANDA   (Italy)

^l JOHNS HOPKINS UNIVERSITY   (United States)

^m UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

ⁿ WEILL CORNELL MEDICAL CENTER   (United States)

^o SAARLAND UNIVERSITY   (Germany)

^p VALDUCE HOSPITAL   (Italy)

^q PAPWORTH HOSPITAL   (United Kingdom)

^r LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^s YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^t Bracco Imaging SpA   (Italy)

^u Bracco Research USA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GADOBENATE DIMEGLUMINE; CONTRAST MEDIUM; DIAGNOSTIC AGENT; DRUG DERIVATIVE; GADOBENIC ACID; MEGLUMINE; ORGANOMETALLIC COMPOUND;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIARRHEA; DIGITAL SUBTRACTION ANGIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; HYPERTENSION; IMAGE QUALITY; INTERMETHOD COMPARISON; KIDNEY ARTERY STENOSIS; KIDNEY FAILURE; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY; TONGUE EDEMA; URINALYSIS; ADOLESCENT; COMPARATIVE STUDY; MIDDLE AGED; PATHOLOGY; PHASE 3 CLINICAL TRIAL; PREDICTION AND FORECASTING; RADIOGRAPHY; RENAL ARTERY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANGIOGRAPHY, DIGITAL SUBTRACTION; CONTRAST MEDIA; FEMALE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PREDICTIVE VALUE OF TESTS; RENAL ARTERY; RENAL ARTERY OBSTRUCTION; SENSITIVITY AND SPECIFICITY;

EID: 42449088131     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2471070711     Document Type: Article

References (61)

1. Prince MR, Narasimham D, Stanley JC, et al. Breath-hold gadolinium-enhanced MR angiography of the abdominal aorta and its major branches. Radiology 1995;197(3):785-792.
2. Holland GA, Dougherty L, Carpenter JP, et al. Breath-hold ultrafast three-dimensional gadolinium-enhanced MR angiography of the aorta and the renal and other visceral abdominal arteries. AJR Am J Roentgenol 1996;166(4):971-981.
3. Snidow JJ, Johnson MS, Harris VJ, et al. Three-dimensional gadolinium-enhanced MR angiography for aortoiliac inflow assessment plus renal artery screening in a single breath hold. Radiology 1996;198(3):725-732.
4. Rieumont MJ, Kaufman JA, Geller SC, et al. Evaluation of renal artery stenosis with dynamic gadolinium-enhanced MR angiography. AJR Am J Roentgenol 1997;169(1):39-44.
5. Prince MR, Schoenberg SO, Ward JS, Londy FJ, Wakefield TW, Stanley JC. Hemodynamically significant atherosclerotic renal artery stenosis: MR angiographic features. Radiology 1997;205(1):128-136.
6. Steffens JC, Link J, Grassner J, et al. Contrast-enhanced, K-space-centered, breathhold MR angiography of the renal arteries and the abdominal aorta. J Magn Reson Imaging 1997;7(4):617-622.
7. Hany TF, Debatin JF, Leung DA, Pfammatter T. Evaluation of the aortoiliac and renal arteries: comparison of breath-hold, contrast-enhanced, three-dimensional MR angiography with conventional catheter angiography. Radiology 1997;204(2):357-362.
8. De Cobelli F, Vanzulli A, Sironi S, et al. Renal artery stenosis: evaluation with breath-hold, three-dimensional, dynamic, gadolinium-enhanced versus three-dimensional, phase-contrast MR angiography. Radiology 1997;205(3):689-695.
9. Bakker J, Beek FJ, Beutler JJ, et al. Renal artery stenosis and accessory renal arteries: accuracy of detection and visualization with gadolinium-enhanced breath-hold MR angiography. Radiology 1998;207(2):497-504.
10. Schoenberg SO, Bock M, Knopp MV, et al. Renal arteries: optimization of three-dimensional gadolinium-enhanced MR angiography with bolus-timing- independent fast multiphase acquisition in a single breath hold. Radiology 1999;211(3):667-679.
11. Thornton MJ, Thornton F, O'Callaghan J, et al. Evaluation of dynamic gadolinium-enhanced breath-hold MR angiography in the diagnosis of renal artery stenosis. AJR Am J Roentgenol 1999;173(5):1279-1283.
12. Shetty AN, Bis KG, Kirsch M, Weintraub J, Laub G. Contrast-enhanced breath-hold three-dimensional magnetic resonance angiography in the evaluation of renal arteries: optimization of technique and pitfalls. J Magn Reson Imaging 2000;12(6):912-923.
13. Bongers V, Bakker J, Beutler JJ, Beek FJ, De Klerk JM. Assessment of renal artery stenosis: comparison of captopril renography and gadolinium-enhanced breath-hold MR angiography. Clin Radiol 2000;55(5):346-353.
14. Mittal TK, Evans C, Perkins T, Wood AM. Renal arteriography using gadolinium enhanced 3D MR angiography: clinical experience with the technique, its limitations and pitfalls. Br J Radiol 2001;74(882):495-502.
15. Fain SB, King BF, Breen JF, Kruger DG, Riederer SJ. High-spatial- resolution contrast-enhanced MR angiography of the renal arteries: a prospective comparison with digital subtraction angiography. Radiology 2001;218(2):481-490.
16. Masunaga H, Takehara Y, Isoda H, et al. Assessment of gadolinium-enhanced time-resolved three-dimensional MR angiography for evaluating renal artery stenosis. AJR Am J Roentgenol 2001;176(5):1213-1219.
17. Mallouhi A, Schocke M, Judmaier W, et al. 3D MR angiography of renal arteries: comparison of volume rendering and maximum intensity projection algorithms. Radiology 2002;223(2):509-516.
18. Schoenberg SO, Rieger J, Johannson LO, et al. Diagnosis of renal artery stenosis with magnetic resonance angiography: update 2003. Nephrol Dial Transplant 2003;18(7):1252-1256.
19. Tan KT, van Beek EJ, Brown PW, et al. Magnetic resonance angiography for the diagnosis of renal artery stenosis: a meta-analysis. Clin Radiol 2002;57(7):617-624.
20. Hany TF, Schmidt M, Hilfiker PR, Steiner P, Bachmann U, Debatin JF. Optimization of contrast dosage for gadolinium-enhanced 3D MRA of the pulmonary and renal arteries. Magn Reson Imaging 1998;16(8):901-906.
21. Dong Q, Schoenberg SO, Carlos RC, et al. Diagnosis of renal vascular disease with MR angiography. RadioGraphics 1999;19(6):1535-1554.
22. Qanadli SD, Soulez G, Therasse E, et al. Detection of renal artery stenosis: prospective comparison of captopril-enhanced Doppler sonography, captopril-enhanced scintigraphy, and MR angiography. AJR Am J Roentgenol 2001;177(5):1123-1129.
23. De Cobelli F, Venturini M, Vanzulli A, et al. Renal artery stenosis: prospective comparison of color Doppler US and breath-hold, three-dimensional, dynamic, gadolinium-enhanced MR angiography. Radiology 2000;214(2):373-380.
24. Rudnick MR, Berns JS, Cohen RM, et al. Nephrotoxic risks of renal angiography: contrast media-associated nephrotoxicity and atheroembolism-a critical review. Am J Kidney Dis 1994;24(4):713-727.
25. Khauli RB. Defining the role of renal angiography in the diagnosis of renal artery disease. Am J Kidney Dis 1994;24(4):679-684.
26. Gilfeather M, Yoon HC, Siegelman ES, et al. Renal artery stenosis: evaluation with conventional angiography versus gadolinium-enhanced MR angiography. Radiology 1999;210(2):367-372.
27. Völk M, Strotzer M, Lenhart M, et al. Time-resolved contrast-enhanced MR angiography of renal artery stenosis: diagnostic accuracy and interobserver variability. AJR Am J Roentgenol 2000;174(6):1583-1588.
28. Korst MB, Joosten FB, Postma CT, Jager GJ, Krabbe JK, Barentsz JO. Accuracy of normal-dose contrast-enhanced MR angiography in assessing renal artery stenosis and accessory renal arteries. AJR Am J Roentgenol 2000;174(3):629-634.
29. Willmann JK, Wildermuth S, Pfammatter T, et al. Aortoiliac and renal arteries: prospective intraindividual comparison of contrast-enhanced three-dimensional MR angiography and multi - detector row CT angiography. Radiology 2003;226(3):798-811.
30. Rankin SC, Jan W, Koffman CG. Noninvasive imaging of living related kidney donors: evaluation with CT angiography and gadolinium-enhanced MR angiography. AJR Am J Roentgenol 2001;177(2):349-355.
31. Leung DA, Hagspiel KD, Angle JF, Spinosa DJ, Matsumoto AH, Butty S. MR angiography of the renal arteries. Radiol Clin North Am 2002;40(4):847-865.
32. Völk M, Strotzer M, Lenhart M, et al. Renal time-resolved MR angiography: quantitative comparison of gadobenate dimeglumine and gadopentetate dimeglumine with different doses. Radiology 2001;220(2):484-488.
33. Kroencke TJ, Wasser MN, Pattynama PM, et al. Gadobenate dimeglumine-enhanced magnetic resonance angiography of the abdominal aorta and renal arteries. AJR Am J Roentgenol 2002;179(6):1573-1582.
34. Prokop M, Schneider G, Vanzulli A, et al. Contrast-enhanced MR angiography of the renal arteries: blinded multicenter crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine. Radiology 2005;234(2):399-408.
35. Klassen PS, Svetkey LP. Diagnosis and management of renovascular hypertension. Cardiol Rev 2000;8(1):17-29.
36. Criteria Committee of the American Heart Association. Nomenclature and criteria for diagnosis of diseases of the heart and great vessels. 9th ed. New York, NY: Little, Brown, 1994.
37. de Haën C, Cabrini M, Akhnana L, Ratti D, Calabi L, Gozzini L. Gadobenate dimeglumine 0.5 M solution for injection (Multi-Hance) pharmaceutical formulation and physicochemical properties of a new magnetic resonance imaging contrast medium. J Comput Assist Tomogr 1999;23(suppl 1):S161-S168.
38. Cavagna FM, Maggioni F, Castelli PM, et al. Gadolinium chelates with weak binding to serum proteins: a new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging. Invest Radiol 1997;32(12):780-796.
39. Giesel FL, von Tengg-Kobligk H, Wilkinson ID, et al. Influence of human serum albumin on longitudinal and transverse relaxation rates (r1 and r2) of magnetic resonance contrast agents. Invest Radiol 2006;41(3):222-228.
40. Pintaske J, Martirosian P, Graf H, et al. Relaxivity of gadopentetate dimeglumine (Magnevist), gadobutrol (Gadovist), and gadobenate dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla. Invest Radiol 2006;41(3):213-221. [Published correction appears in Invest Radiol 2006;41(12):859.]
41. Laurent S, Elst LV, Muller RN. Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents. Contrast Media Mol Imaging 2006;1(3):128-137.
42. Wikstrom J, Wasser MN, Pattynama PM, et al. Gadobenate dimeglumine-enhanced magnetic resonance angiography of the pelvic arteries. Invest Radiol 2003;38(8):504-515.
43. Broome DR, Girguis MS, Baron PW, Cottrell AC, Kjellin I, Kirk GA. Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned. AJR Am J Roentgenol 2007;188(2):586-592.
44. Sadowski EA, Bennett LK, Chan MR, et al. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology 2007;243(1):148-157.
45. Vasbinder GB, Nelemans PJ, Kessels AG, et al. Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis. Ann Intern Med 2004;141(9):674-682.
46. Schaefer PJ, Boudghene FP, Brambs HJ, et al. Abdominal and iliac arterial stenoses: comparative double-blinded randomized study of diagnostic accuracy of 3D MR angiography with gadodiamide or gadopentetate dimeglumine. Radiology 2006;238(3):827-840.
47. McGregor R, Vymazal S, Martinez Lopez M, et al. A multi-center, comparative, phase III study to determine the efficacy of gadofosveset-enhanced magnetic resonance angiography for evaluation of renal artery disease. Europ J Radiol doi:10.1016/j.ejrad.2007.03.018. Published online May 11, 2007. Accessed December 21, 2007.
48. Goyen M, Edelman M, Perreault P, et al. MR angiography of aortoiliac occlusive disease: a phase III study of the safety and effectiveness of the blood-pool contrast agent MS-325. Radiology 2005;236(3):825-833.
49. Rapp JH, Wolff SD, Quinn SF, et al. Aortoiliac occlusive disease in patients with known or suspected peripheral vascular disease: safety and efficacy of gadofosveset-enhanced MR angiography - multicenter comparative phase III study. Radiology 2005;236(1):71-78.
50. Vasbinder GB, Nelemans PJ, Kessels AG, et al. Diagnostic tests for renal artery stenosis in patients suspected of having renovascular hypertension: a meta-analysis. Ann Intern Med 2001;135(6):401-411.
51. Grist TM. Magnetic resonance angiography of renal artery stenosis. Coron Artery Dis 1999;10(3):151-156.
52. Anzalone N, Scomazzoni F, Castellano R, et al. Carotid artery stenosis: intraindividual correlations of 3D time-of-flight MR angiography, contrast-enhanced MR angiography, conventional DSA, and rotational angiography for detection and grading. Radiology 2005;236(1):204-213.
53. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33(1):159-174.
54. Dujardin B, Van den Ende J, Van Gompel A, et al. Likelihood ratios: a real improvement for clinical decision making? Eur J Epidemiol 1994;10(1):29-36.
55. Jaeschke R, Guyatt JH, Sackett DL. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA 1994;271(9):703-707.
56. Cambria RP, Kaufman JL, Brewster DC, Gertler JP, LaMuraglia GM, Bazari H. Surgical renal artery reconstruction without contrast arteriography: the role of clinical profiling and magnetic resonance angiography. J Vasc Surg 1999;29(6):1012-1021.
57. Bude RO, Forauer AR, Caoili EM, Nghiem HV. Is it necessary to study accessory arteries when screening the renal arteries for renovascular hypertension? Radiology 2003;226(2):411-416.
58. Wilson GJ, Hoogeveen RM, Willinek WA, Muthupillai R, Maki JH. Parallel imaging in MR angiography. Top Magn Reson Imaging 2004;15(3):169-185.
59. Wilson GJ, Eubank WB, Vasbinder GB, et al. Utilizing SENSE to reduce scan duration in high-resolution contrast-enhanced renal MR angiography. J Magn Reson Imaging 2006;24(4):873-879.
60. Knopp MV, Schoenberg SO, Rehm C, et al. Assessment of gadobenate dimeglumine for magnetic resonance angiography: phase I studies. Invest Radiol 2002;37(12):706-715.
61. Knopp MV, Giesel FL, von Tengg-Kobligk H, et al. Contrast-enhanced MR angiography of the run-off vasculature: intraindividual comparison of gadobenate dimeglumine with gadopentetate dimeglumine. J Magn Reson Imaging 2003;17(6):694-702.